BriaCell Announces Pricing of US$25 Million Public Offering and Nasdaq Listing

NEXT STORY
Number of shares and voting rights of Innate Pharma as of February 1, 2021
PREV STORY
Predictive Oncology Announces Closing of $17.6 Million Private Placement Priced At-the-Market
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

IBA and NorthStar Medical Radioisotopes Sign Contract for Rhodotron® Electron Beam Accelerator for Commercial Production of Therapeutic Radioisotope Actinium-225 (Ac-225)

author_avatar
NASDAQ Market News

BeiGene Announces Oral Presentation and Posters at the 59th American Society of Hematology Annual Meeting

CAMBRIDGE, Mass. and BEIJING, China, Nov. 01, 2017 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ:BGNE), ...

author_avatar
NASDAQ Market News

Square 1 Bank Announces Credit Facility to Recursion Pharmaceuticals

SAN DIEGO, June 05, 2018 (GLOBE NEWSWIRE) -- Square 1 Bank, a division of ...

author_avatar
NASDAQ Market News